Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "Steven A. Narod" Clear advanced filters

  • Genetic testing for breast cancer susceptibility is widely available in North America and in Europe. The optimum treatment of women with breast (or ovarian) cancer and aBRCA1 or BRCA2 mutation may be different from that of non-carriers. Thus, identifying the BRCAmutation status in patients could assist appropriate decision making for individualized cancer prevention, screening and treatment.

    • Steven A. Narod
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 7, P: 702-707

  • The diagnostic utility of tumor size in breast cancer is dependent on multiple factors. In this Perspective, Foulkes and coauthors recommend that tumor size should not be automatically considered in treatment decisions for all breast cancer subtypes. The authors discuss how the correlation between size and survival is disrupted in triple-negative and basal-like breast cancers and propose two specific mechanisms that might be responsible for this disrupted relationship.

    • William D. Foulkes
    • Jorge S. Reis-Filho
    • Steven A. Narod
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 7, P: 348-353

  • Hormone replacement therapy (HRT) has been linked by several reports to an increased risk of breast cancer. The precipitous decrease in breast cancer incidence shortly after the cessation of HRT is well established. In this Review, Steven Narod summarizes the evidence and asks the question, where do the breast cancers go?

    • Steven A. Narod
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 8, P: 669-676

  • This Opinion article outlines a set of research priorities, based on discussions held at the 2015 Helene Harris Memorial Trust Ovarian Cancer Action meeting, that the authors believe will reduce incidence and improve outcomes for women with high-grade serous ovarian cancer.

    • David D. Bowtell
    • Steffen Böhm
    • Frances R. Balkwill
    Reviews
    Nature Reviews Cancer
    Volume: 15, P: 668-679

  • Breast cancers in young women are typically aggressive and so young age can correlate with a poorer outcome. In this Review article, Steven Narod discusses the risk factors, risks of recurrence and secondary cancer, treatment, prevention and awareness of very-early onset breast cancer.

    • Steven A. Narod
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 9, P: 460-470